TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Tilray Brands, Inc.
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$3.03−0.01 (-0.33%)
Close on Oct 19, 2026
- Market cap
- $404.02M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$12.57 (−80.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Tilray Brands, Inc. grew revenue 15.9% to $963.10M over the twelve months to Aug 31, 2026.
Revenue
$963.10M
+15.9% vs. a year earlier
Operating income
-$89.17M
TTM Q1 2027
EPS, diluted
-$1.39
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Aug 31, 2026
Valuation
- Market cap
- $404.02M
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- 0.25
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $963.10M
- Net income
- -$164.22M
- EPS, diluted
- -$1.39
- Book value per share
- $12.17
- Diluted shares
- 133M
Ten years at a glance
Fiscal years 2015 to 2026 and trailing twelve months, USD
Revenue
$963.10M+15.9% YoY
Gross profit
$280.48M+17.7% YoY
Operating income
-$89.17M
Net income
-$164.22M
EPS, diluted
-$1.39
Free cash flow
–
Reported periodTrailing twelve months